![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Excess omega-3 fatty acids could lead to negative health effects
A new review suggests that omega-3 fatty acids taken in excess could have unintended health...
International collaboration finds 11 new Alzheimer’s genes to target for drug discovery
University of Miami Miller School of Medicine researchers played a key role in the largest...
AstraZeneca oncology portfolio strengthened as MedImmune acquisition of Spirogen boosts antibody-drug conjugate capability
AstraZeneca today announced that MedImmune, its global biologics research and development arm, has acquired Spirogen,...
Human skin wound dressings to treat cutaneous ulcers
Researchers from Université Laval's Faculty of Medicine and CHU de Québec have shown that it...
Takeda and Lundbeck announce FDA approval of Brintellix™
H. Lundbeck A/S (Lundbeck) and Takeda Pharmaceutical Company Limited (Takeda) jointly announced that the U.S....
Malaria No More and Novartis launch Power of One, a global digital fundraising campaign...
Novartis and Malaria No More announced today the debut of the Power of One campaign,...
GSK signs a multi-year agreement with BARDA to supply the US government with anthrax...
GlaxoSmithKline (GSK) plc has announced a new four year contract with the Biomedical Advanced Research...
AstraZeneca and Merck enter licence agreement for investigational oral WEE1 kinase inhibitor therapy for...
AstraZeneca announced that MedImmune, its global biologics research and development arm, has entered into a...
Statins being overprescribed for growing number of kidney disease patients
A new analysis concludes that large numbers of patients in advanced stages of kidney disease...
SAVOR-TIMI 53 sets new standard for cardiovascular outcome trials in diabetes
Uncertainty persists regarding whether drugs that lower sugar reduce the risk of heart attack, with...